The TRAILBLAZER-ALZ 6 Study
About the TRAILBLAZER-ALZ 6 Study
The TRAILBLAZER-ALZ 6 study is evaluating whether different doses of an investigational drug are safe and effective for people with the early stages of Alzheimer’s disease.
About the TRAILBLAZER-ALZ 6 Study
The TRAILBLAZER-ALZ 6 study is evaluating whether different doses of an investigational drug are safe and effective for people with the early stages of Alzheimer’s disease.
You or a loved one may be able to take part in the TRAILBLAZER-ALZ 6 Study if you:
- Are 60 to 85 years of age
- Have memory loss that has gotten worse over time
- Have a trusted study partner* who knows you well and is willing to attend appointments with you throughout the study
- Meet additional study needs
*The study partner must be able to speak about the participant’s day-to-day routines and any changes with the research staff throughout the study.
If you are interested in participating, the study doctor and staff will review additional eligibility criteria with you.
Study Overview
There are 4 groups. Each group gets a different dose of the investigational drug. Participants may get the investigational drug at some visits and the placebo at other visits.
The study can last up to about 1 year and 9 months.
For more information:
